← back to search

Hui Yang

Shandong First Medical University · CN
Area of research
Molecular Biology · Plant Science
Research interest
Research interests include CRISPR and Genetic Engineering, Soybean genetics and cultivation, Gut microbiota and health, and RNA regulation and disease.
h-index
40
citations
6,360
works
136
NIH funding
primary concept
Biology
email

Recent publications

Cas13-Mediated RNA Base Editing for the Treatment of Hereditary Hypertrophic Cardiomyopathy.
2026cited by 0position: contributordoi
A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques
Molecular Therapy Methods & Clinical Development 2025cited by 10position: contributordoi
Characterization of Main Responsive Genes Reveals Their Regulatory Network Attended by Multi-Biological Metabolic Pathways in Paclobutrazol (PAC)-Modulated Grape Seed Development (GSD) at the Stone-Hardening Stage
International Journal of Molecular Sciences 2025cited by 4position: middledoi
Epigenetic editing alleviates Angelman syndrome phenotype in mice by unsilencing paternal Ube3a
Cell Discovery 2024cited by 12position: contributordoi
Programmable G-to-Y base editing using engineered DNA glycosylase.
2024cited by 0position: contributordoi
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.
2023cited by 171position: contributordoi
Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase.
2023cited by 147position: contributordoi
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing.
2023cited by 69position: contributordoi
Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase.
2023cited by 56position: contributordoi
A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice.
2023cited by 31position: contributordoi
An engineered xCas12i with high activity, high specificity, and broad PAM range.
2023cited by 29position: contributordoi
Mini-dCas13X-mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy.
2023cited by 28position: contributordoi
Ptbp1 knockdown failed to induce astrocytes to neurons in vivo.
2023cited by 20position: contributordoi
Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e.
2023cited by 19position: contributordoi
Limitations of gene editing assessments in human preimplantation embryos.
2023cited by 18position: contributordoi
Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editor.
2023cited by 2position: contributordoi
A functionally divergent SOC1 homolog improves soybean yield and latitudinal adaptation
Current Biology 2022cited by 119position: middledoi
Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor
Science Translational Medicine 2022cited by 98position: middledoi
Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor.
2022cited by 62position: contributordoi
Mitochondrial base editor DdCBE causes substantial DNA off-target editing in nuclear genome of embryos.
2022cited by 56position: contributordoi
Gene editing in a Myo6 semi-dominant mouse model rescues auditory function.
2022cited by 53position: contributordoi
Downregulation of a gibberellin 3β‐hydroxylase enhances photosynthesis and increases seed yield in soybean
New Phytologist 2022cited by 53position: middledoi
Human cleaving embryos enable efficient mitochondrial base-editing with DdCBE.
2022cited by 30position: contributordoi
Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice
Cell Research 2022cited by 27position: middledoi
Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice.
2022cited by 19position: contributordoi
Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration.
2022cited by 19position: contributordoi
Ectopic expression of GmRNF1a encoding a soybean E3 ubiquitin ligase affects Arabidopsis silique development and dehiscence
Planta 2022cited by 7position: middledoi
Author Correction: Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.
2022cited by 3position: contributordoi
Ptbp1 knockdown failed to induce astrocytes to neurons in vivo
2022cited by 0position: contributordoi
Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes.
2021cited by 277position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Hui Yang · Nanjing Agricultural University45 papers (2019–2026) · 28 papers (2019–2026)Linyu Shi · Shanxi Medical University7 papers (2018–2023)Tanglong Yuan · Agricultural Genomics Institute at Shenzhen5 papers (2019–2022)Bingbing He · Elsevier, Inc.4 papers (2020–2023)Huawei Tong · Chinese Academy of Sciences4 papers (2023–2024)Deyue Yu · Nanjing Agricultural University4 papers (2016–2022)Fang Huang · Nanjing Agricultural University4 papers (2016–2022)Wu Wei · Shandong Agricultural University3 papers (2019–2020)Erwei Zuo · Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences3 papers (2020–2020)Yidi Sun · Institute of Modern Physics3 papers (2019–2020) · 3 papers (2023–2026)Chunlong Xu · China Agricultural University3 papers (2022–2023) · 3 papers (2020–2021)Haiyang Li · Nanjing Agricultural University3 papers (2020–2021)Zi‐Jiang Chen · Ministry of Education of the People's Republic of China3 papers (2018–2023)Wenqin Ying · Chinese Academy of Sciences2 papers (2019–2020) · 2 papers (2020–2024)Jinsheng Lai · China Agricultural University2 papers (2021–2022)Yixue Li · Taizhou University2 papers (2019–2020)